Rate of guideline-concordant care was 59.7 percent overall and increased with increasing Lung-RADS score in adults 65 years or older.
SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...